INTRODUCTION
Maintenance of a wide array of adult tissues is dependent on the presence of a resident stem cell pool with self-renewal potential that generates differentiating progeny. Factors regulating the balance between stem cell self-renewal and differentiation ensure tissue homeostasis whereas disruption of these regulatory mechanisms can lead to tissue degeneration or cancer (Ito et al., 2009) . One factor central to stem cell homeostasis is mammalian TOR complex 1 (mTORC1), a signaling complex that promotes protein translation and cell growth by phosphorylating components of the translation machinery (Ma and Blenis, 2009) . mTORC1 is regulated in response to diverse stimuli including nutrient availability, energy status, growth factors, and cellular stress. Persistent mTORC1 activation in certain tissues leads to increased proliferation but subsequent exhaustion of the stem cell compartment, demonstrating that aberrantly activated mTORC1 is detrimental to stem cell maintenance (Castilho et al., 2009; Gan and DePinho, 2009; Yilmaz et al., 2006) . It is proposed that inappropriate mTORC1 activation drives stem cell depletion through aberrant translation of downstream targets and subsequent activation of tumor suppressive/ fail-safe mechanisms resulting in cellular senescence or apoptosis (Ito et al., 2009 ). However, the molecular mechanisms and targets of mTORC1 in this context are currently unknown. Interestingly, inhibition of mTORC1 also extends organism lifespan (Harrison et al., 2009; Schieke and Finkel, 2006) , consistent with the notion that declining stem cell potential underlies aging (Rossi et al., 2008) .
Undifferentiated germline cells of the testis (spermatogonial progenitor cells; SPCs) are formed from gonocytes during postnatal development of the mouse testis and possess self-renewal potential (de Rooij and Russell, 2000) . A major advance in the study of male germline biology was the development of culture systems allowing long-term SPC expansion in vitro while maintaining stem cell potential. Key to this was the observation that mice heterozygous for the glial cell-derived neurotrophic factor (GDNF) cytokine gene had a depletion of SPC activity (Meng et al., 2000) . GDNF is produced by Sertoli cells within the testis, and signals via the GFRa1/c-Ret receptor to promote SPC selfrenewal and growth through activation of Src family kinases and Akt (Lee et al., 2007b; Oatley et al., 2007) . Culture of SPCs with GDNF plus a variety of additional factors (including basic fibroblast growth factor; bFGF) preserves self-renewal capabilities and allows essentially unlimited cell expansion while maintaining in vivo differentiation potential; assessed by the ability to repopulate depleted recipient testis (Kanatsu-Shinohara et al., 2003; Kubota et al., 2004; Seandel et al., 2007) . Although some cellular signaling pathways involved in SPC self-renewal have been described, it remains unclear how SPCs integrate signals from general mitogenic stimuli with those required for self-renewal to balance stem cell maintenance and differentiation.
A limited number of cell intrinsic factors have also been implicated in SPC function, foremost among which is promyelocytic leukemia zinc finger (PLZF). PLZF was identified from the translocation breakpoint in t(11;17) acute promyelocytic leukemia (Chen et al., 1993) and encodes a transcription factor belonging to the POZ-Kru¨ppel (POK) family. PLZF binds DNA through carboxy-terminal Kru¨ppel-type zinc fingers and recruits histone deacetylases (HDACs) via an amino-terminal POZ domain (David et al., 1998) . Recruitment of HDACs to target promoters can result in gene repression although PLZF is also able to activate gene expression (Doulatov et al., 2009; Labbaye et al., 2002) . Male mice lacking Plzf expression undergo progressive germ cell loss and testis atrophy with age causing infertility (Buaas et al., 2004; Costoya et al., 2004) . Plzf is expressed by SPCs and is needed in a cell autonomous fashion for maintenance of the germ lineage. A male patient with biallelic PLZF loss-offunction and gonad hypoplasia has been recently reported (Fischer et al., 2008) , emphasizing the role played by PLZF in germ cell biology.
SPC maintenance is dependent on Plzf plus key growth factors such as GDNF. As mTORC1 is activated in response to growth factor signaling we hypothesized that both Plzf and mTORC1 are involved in the GDNF response of SPCs and that Plzf and mTORC1 may crosstalk. To assess the roles of Plzf and mTORC1 in GDNF-dependent SPC maintenance, we developed systems for isolation and culture of SPCs from wild-type (WT) and Plzf À/À prepubertal mice (subsequent to formation of the SPC pool and prior to overt germ cell depletion in the Plzf À/À mouse). We find that Plzf opposes mTORC1 activity and define a cellular signaling network controlling SPC homeostasis whereby mTORC1 integrates mitogenic signals received by SPCs and determines their sensitivity to self-renewal stimuli.
RESULTS
Isolation, Culture, and Comparative Analysis of Plzf +/+ and Plzf À/À SPCs
The testis is composed of a heterogeneous mix of mitotic and meiotic germ cells plus multiple types of somatic cells. SPCs are rare within the testis and systems for their purification are poorly developed. We therefore sought to take advantage of the expression of Plzf in SPCs to enrich for this cell type. Plzfexpressing cells were identified from juvenile testis by intracellular staining and flow cytometry using a newly developed monoclonal antibody ( Figure 1A ). Our aim was to correlate the Plzf-expressing population to sets of cell surface markers that would allow subsequent purification of those live cells. By adapting markers able to enrich for stem cell activity from cryptorchid testis (Kubota et al., 2003; Shinohara et al., 2000) , we found that the Plzf-positive population was av-integrin negative and expressed low levels of Thy-1 ( Figure 1B ). Negative selection for av-integrin combined with Thy-1 positive selection allowed isolation of Plzf-positive cells and minimized somatic cell contamination (Figures S1A and S1B available online) (Virtanen et al., 1986) . c-Kit expression is associated with SPC differentiation (Schrans-Stassen et al., 1999) and the av neg Thy-1 low population was composed primarily of c-Kit negative cells with a smaller c-Kit positive fraction ( Figure 1C , left). The c-Kit neg cells
were largely in G 1 /G 0 phase of cell cycle whereas the c-Kit pos population contained more cells in S plus G 2 phases ( Figure 1C , right). As SPCs are more quiescent than differentiating spermatogonia (Ogawa et al., 1997) . Donor cells were isolated from transgenic mice expressing GFP from the b-actin promoter, allowing visualization of donor-derived colonies ( Figure 1D, left) . Numbers of GFPpositive colonies were scored 2 months posttransplant (Figure 1D, Figure 1D ) and an estimated 10% engraftment efficiency (Nagano et al., 1999) was depleted relative to the WT ( Figure 1E and Figure S1C ) and the percentage of c-Kit pos cells within the Plzf À/À av neg Thy-1 low fraction was increased ( Figure 1F and Figure S1D ).
The decreased frequency and numbers of av neg Thy-1 low c-Kit neg cells in Plzf À/À testis ( Figure 1G ) confirms that Plzf loss is detrimental to SPCs whereas the increase in c-Kit pos cells within the av neg Thy-1 low fraction is suggestive of increased differentiation commitment. As Plzf directly represses c-Kit expression (Filipponi et al., 2007) , this can be reflective of a de-repression of the c-Kit locus. However, the Plzf À/À av neg Thy-1 low fraction still contains c-Kit neg cells ( Figure 1F and Figure S1D) Figure 1H and Figure S1E ) Ohbo et al., 2003; Wu et al., 2010; Yoshida et al., 2006) , confirming the identity of this fraction. We also noted that Plzf À/À av neg Thy-1 low cells had decreased levels of b1 and a6 integrins but equivalent levels of CD9 compared to controls (Figures S1F and S1G) (Kanatsu-Shinohara et al., 2004b; Shinohara et al., 1999) . Our data indicate that SPCs from juvenile Plzf À/À mice have an impaired ability to maintain an undifferentiated state, which precedes overt germ cell loss. We next attempted in vitro culture of isolated Plzf +/+ and Plzf À/À SPCs, adapting previously developed culture systems (Kubota et al., 2004; Seandel et al., 2007) . As anticipated, germ cell colony-forming activity under SPC culture conditions was essentially entirely contained within the av neg Thy-1 low fraction ( Figure S2A ). We successfully derived SPC lines from both Plzf +/+ and Plzf À/À av neg Thy-1 low cells, which grew as discrete colonies on mouse embryonic fibroblast (MEF) feeder cells ( Figure 2A ) and maintained their cell surface marker identity during exponential growth over 1 year of culture ( Figure S2B ). WT SPC lines expressed Plzf ( Figure 2B) Figure 5C ). The ability to culture Plzf À/À SPCs seemed counterintuitive, but the generation of these cultures became critical for further dissection of Plzf function and to the solution of this apparent contradiction. An additional indicator of SPC potential is the ability to derive embryonic stem-like cells from the cultured lines (multipotent adult spermatogonial-derived stem cells; MASCs) (Kanatsu- Shinohara et al., 2004a; Seandel et al., 2007) . We observed spontaneous formation of MASC colonies from two of seven WT lines ( Figure S2E ). MASC formation was not observed in four Plzf À/À SPC lines, possibly indicating a defective capability to generate MASCs. The multipotent capabilities of MASC lines were verified by teratoma formation assay ( Figure S2F ). On SPC to MASC conversion, expression of the pluripotency-associated factors Pou5f1/Oct4, Sox2 and Nanog were substantially increased whereas Plzf expression was lost ( Figure S2G and data not shown) (Seandel et al., 2007) . Formation of MASCs indicates that SPC potential is maintained in our culture system, whereas the apparent inability of Plzf À/À SPCs to form MASCs can be consistent with their defective function.
From analysis of cultured SPC lines, we noticed that Plzf À/À cells were physically larger than WT SPCs, measured by the FSC parameter of flow cytometry ( Figures 2C and 2D ). Alterations in cell size are associated with changes in activity of mTORC1 acting through its downstream targets S6Kinase1 (S6K1), which phosphorylates ribosomal S6 protein (RPS6), and 4EBP1 (Fingar et al., 2002; Ruvinsky et al., 2005) . Given the role of mTORC1 in hematopoietic stem cells (Gan and DePinho, 2009 ), we considered that aberrant mTORC1 activity in Plzf À/À SPCs could contribute to their defective maintenance. Importantly, Plzf
SPCs had elevated levels of phosphorylated RPS6 compared to WT cells, confirming increased mTORC1 activity ( Figure 2E and Figure 3C ). Inhibition of mTORC1 with rapamycin decreased the size of Plzf À/À SPCs to that of WT cells suggesting that elevated mTORC1 activity was responsible for the size increase ( Figure 2F ). Rapamycin was confirmed to inhibit RPS6 phosphorylation in Plzf À/À SPCs ( Figure 2E ). Increased mTORC1 activity in Plzf À/À SPCs was associated with elevated levels of cellular protein ( Figure S2H ), consistent with the role of mTORC1 in regulating protein translation. Importantly, freshly isolated Plzf À/À SPCs were also physically larger (Figures 2G and 2H) and rapamycin treatment of Plzf À/À mice normalized SPC size (Figures 2G and 2H) . Together, our data indicate that Plzf inhibits mTORC1 activation in SPCs.
Growth Factor-Mediated Regulation of mTORC1 in SPCs Given the possibility that mTORC1 activity can regulate SPC function, we next defined key regulatory inputs of mTORC1 in WT SPCs. Growth factor signaling represents a major activating input of mTORC1 (Ma and Blenis, 2009; Shaw and Cantley, 2006) and mTORC1 inhibition interferes with mitogenic stimuli causing cell cycle arrest (Brown et al., 1994) . Indeed, rapamycin suppressed SPC colony growth and caused an accumulation of cells in G1 phase of the cell cycle ( Figures S3A and S3B ). Growth factor receptors activate mTORC1 by signaling through phosphoinositide 3-kinase (PI3K)/Akt and Ras/Erk MAPK, which inhibit the TSC1/TSC2 complex (Huang and Manning, 2008) ; TSC1/TSC2 negatively regulates mTORC1 via its GTPase-activating protein activity toward the small G protein Rheb. Treatment of WT SPCs with PI3K/Akt or Erk MAPK pathway inhibitors significantly reduced levels of phosphorylated RPS6 ( Figure 3A ), indicating that efficient mTORC1 activation in SPCs requires both PI3K/Akt and Erk MAPK. Inhibition of Src family kinases, implicated in the GDNF response of SPCs (Oatley et al., 2007) , had modest effects on phospho-RPS6 ( Figure 3A) . Therefore, despite the ability of Src family kinases to activate PI3K/Akt downstream GDNF (Encinas et al., 2001; Oatley et al., 2007) , this SPC self-renewal pathway couples inefficiently to mTORC1.
SPCs are maintained with a cocktail of growth factors (Kanatsu- Shinohara et al., 2003; Seandel et al., 2007) and are responsive to others (Hamra et al., 2007) ; thus we next assessed contributions of these factors to mTORC1 activation in WT SPCs. We found that GDNF triggered a modest phosphorylation of RPS6 whereas other mitogens (including bFGF) induced much under steady-state conditions is shown to the left. Quantification of the relative levels of phospho-Akt, Erk, and RPS6 (corrected to the total levels of respective proteins) are shown in panels on the right. See also Figure S3 .
higher levels of phospho-RPS6 ( Figure 3B ). The relative abilities of GDNF and bFGF to activate mTORC1 correlated to their efficiency of Akt and Erk activation ( Figure 3B ). However, this correlation did not hold true for epidermal growth factor (EGF) stimulation, possibly reflecting additional pathways by which EGF activates mTORC1 (Fan et al., 2009 ). In summary, the self-renewal signal GDNF poorly activates mTORC1 when compared to more general mitogens for SPCs (bFGF, EGF), in agreement with the Src kinase inhibition data (see above). However, we note that although GDNF is considered the key SPC self-renewal signal, SPC expansion and self-renewal in vitro requires a combination of GDNF plus other factors (e.g., bFGF) that stimulate mTORC1 more efficiently (Lee et al., 2007b) .
Plzf Uncouples mTORC1 Activity from Growth Factor Signaling in SPCs through Redd1 Modulation Given that mTORC1 activity in SPCs is regulated by growth factors present in the culture medium and resultant PI3K/Akt and Erk-MAPK activation, we next assessed whether the elevated mTORC1 activity of Plzf À/À SPCs correlated with an enhanced growth factor response. However, in comparison to WT cells, the Akt and Erk activities of steady-state Plzf À/À SPCs were decreased whereas phospho-RPS6 was increased ( Figure 3C ), indicating that the elevated mTORC1 activity is not due to increased activity of growth factor pathways. We next considered alternative mechanisms by which mTORC1 activity would be increased in Plzf À/À SPCs. Cellular stress-response pathways provide additional regulatory inputs resulting in mTORC1 inhibition when conditions such as low energy availability or hypoxia require temporary arrest of cell growth (Huang and Manning, 2008) . We hypothesized that mTORC1 hyperactivity in Plzf À/À SPCs could be due to reduced activity of stress response pathways. Accordingly, we first assessed levels of upstream regulatory proteins as stress pathways converge on mTORC1 at the level of TSC1/TSC2. However, we did not find significant differences in levels of Tsc1, Tsc2, Rheb, or the mTOR kinase itself in Plzf À/À SPCs compared to WT cells ( Figure 4A ). By contrast, we noticed that levels of Redd1 (also known as Ddit4, Rtp801, and Dig2) were substantially lower in Plzf À/À SPCs compared to controls, at both protein and mRNA levels ( Figures 4A and 4B ). Redd1 is induced by multiple types of cell stress (e.g., hypoxia, DNA damage) and by developmental signals and inhibits mTORC1 through regulation of TSC1/TSC2 (Brugarolas et al., 2004; Corradetti et al., 2005; Ellisen et al., 2002) . As a role for Redd1 in SPCs is not described, we analyzed the distribution of Redd1 expression in isolated spermatogonial fractions and found a relative enrichment of Redd1 mRNA in SPCs ( Figure 4C ). We also confirmed that freshly isolated Plzf À/À SPCs had lower Redd1 expression compared to controls ( Figure 4C ). Furthermore, shRNA knockdown of Redd1 in WT SPCs increased mTORC1 activity ( Figure 4D and Figure S4 ). Together, our data suggest that Plzf opposes mTORC1 by maintaining Redd1 expression and that Redd1 is a key mTORC1 regulator in SPCs.
Plzf Is a Transcriptional Activator of the mTORC1 Inhibitor Redd1 in SPCs
Redd1 expression was decreased at the mRNA level in Plzf À/À SPCs. We therefore tested whether Plzf could directly induce Redd1 expression. We first performed a chromatin Figure S4 ). immunoprecipitation (ChIP) assay to assess whether Plzf was bound to the Redd1 promoter in SPCs. We scanned a 2-kb region upstream Redd1 that contains binding sites for multiple transcription factors known to regulate Redd1 expression ( Figure 4E ) (Ellisen et al., 2002; Lin et al., 2005; Shoshani et al., 2002) . Importantly, we could detect Plzf association with distal promoter (DP) regions but not proximal promoter (PP) regions ( Figure 4E ), indicating that Plzf regulates Redd1 expression through recruitment to the DP. To confirm this we performed luciferase assays with REDD1 promoter constructs containing both DP+PP elements and the PP element alone ( Figure 4F ). In agreement with our ChIP results, PLZF activated the DP+PP construct but not the PP construct. Further, deletion of the PLZF POZ domain prevented PP+DP reporter activation, indicating a requirement for this protein-protein interaction domain. We conclude that Plzf directly activates Redd1 through the DP to inhibit mTORC1 in SPCs.
Active mTORC1 Inhibits SPC Self-Renewal Pathways via a Negative Feedback Loop As Plzf À/À SPCs show increased mTORC1 but decreased Akt activities ( Figure 3C ), we considered that negative feedback from mTORC1 could prevent Plzf À/À cells from activating Akt in response to growth factors. In cells lacking TSC1/TSC2, increased mTORC1-signaling induces a negative feedback loop from the mTORC1 downstream target S6K to upstream signaling components causing inhibition of PI3K/Akt (Harrington et al., 2004; Shah et al., 2004 ). Therefore, we tested whether aberrant mTORC1 activity inhibited the response of Plzf
SPCs to GDNF, a growth factor required for SPC self-renewal, which could explain the maintenance defect of Plzf À/À SPCs.
We compared the response of starved Plzf +/+ and Plzf
À/À
SPCs to GDNF in the absence or presence of rapamycin to vary mTORC1 activity ( Figures 5A and 5B Plzf À/À SPC growth was inhibited more substantially than that of the WT cells ( Figure 5C ). A decreased sensitivity to GDNF due to negative feedback from mTORC1 can explain the defect in Plzf À/À SPC maintenance in vivo when levels of GDNF are limiting (Meng et al., 2000) and how Plzf À/À SPCs can be cultured in vitro when GDNF is supplied to excess. Importantly, GDNF expression in Plzf À/À testis was equivalent to that of the WT (Figure S5 ), ruling out noncell autonomous defects in production of niche factors.
Activated mTORC1 Suppresses Expression of GDNF Receptor Components
We next sought to determine the mechanism by which activated mTORC1 inhibits response of Plzf À/À SPCs to GDNF. Negative feedback from mTORC1 to PI3K/Akt was originally characterized in the context of insulin responsiveness and signaling through IRS1/2 proteins (Harrington et al., 2005) . Although IRS proteins have been implicated in activation of PI3K by the GDNF receptor component c-Ret (Hennige et al., 2000) , we noticed that expression of the GDNF receptor components GFRa1 and c-Ret in SPCs were responsive to rapamycin ( Figures 5D and 5E ). Cultured Plzf À/À SPCs expressed lower levels of GFRa1 and c-Ret compared to WT cells (correlating with reduced GDNF-responsiveness) but on mTORC1 inhibition, expression of these GDNF receptor components was increased back to WT levels. Expression of GFRa1 and c-Ret were also lower in freshly isolated Plzf À/À SPCs compared to WT SPCs ( Figure 5F ), confirming that Plzf loss disrupts GDNF receptor expression in vivo. Our data suggest that aberrantly activated mTORC1 inhibits the response of Plzf À/À SPCs to GDNF by opposing expression of the receptor. Interestingly, mTORC1 inhibits upstream signaling events in MEFs through transcriptional inhibition of the PDGF receptor . In SPCs, negative feedback between mTORC1 and the GDNF receptor will lead to loss of self-renewal when mTORC1 is hyperactivated, such as occurs on loss of Plzf expression ( Figure S6A ). This feedback loop would inversely couple cell growth to selfrenewal, so that on expansion of the stem cell pool by mitogenic stimulation and resultant mTORC1 activation, response of the cells to self-renewal signals is inhibited, restricting stem cell numbers. Interestingly, GDNF activates mTORC1 weakly in SPCs when compared to other mitogens (e.g., bFGF) ( Figure 3B ), suggesting that GDNF would trigger a limited activation of the negative feedback response whereas bFGF could cause more extensive inhibition of GDNF signaling via mTORC1. Figure 6A ). We conclude that aberrant mTORC1 activation can explain, at least in part, the SPC maintenance defect of Plzf À/À mice.
Intriguingly, rapamycin also increased the frequency of SPCs in WT mice ( Figure 6B ), suggesting that mTORC1 inhibition stimulates SPC function in a WT setting. Indeed, in WT SPCs, rapamycin enhanced Akt activation in response to GDNF (Figures 5A and 5B) and increased GDNF receptor expression ( Figures 5D and 5E ). Importantly, prolonged rapamycin treatment of juvenile WT mice increased the number of cells with high levels of Plzf expression in the testis ( Figures 6C and 6D and Figure S6B ) and enhanced GDNF receptor expression ( Figure S6C ), suggesting that physiological mTORC1 activity controls size and function of the SPC pool in vivo.
DISCUSSION
Disruption of genes encoding for negative regulators of the PI3K/ Akt/mTORC1 pathway (e.g., Pten, Tsc1, and Pml) leads to loss of hematopoietic stem cell (HSC) quiescence and subsequent exhaustion. Rapamycin prevents HSC depletion, demonstrating that aberrant mTORC1 activation is responsible for stem cell loss Gan et al., 2008; Ito et al., 2008; Yilmaz et al., 2006) . The negative effects of mTORC1 on HSC maintenance have been attributed to its downstream targets in cell growth pathways and aberrant mTORC1 activity elicits activation of tumor suppressive mechanisms that can contribute to stem cell failure ( Figure S6D ) (Alimonti et al., 2010; Lee et al., 2007a) . By studying Plzf function in SPCs, we now implicate negative feedback responses from the mTORC1 pathway to receptors required to transduce niche-derived selfrenewal signals in the loss of stem cell potential ( Figure S6E ).
HSC maintenance is also linked to niche signals acting through growth factor receptors (Arai et al., 2004; Yoshihara et al., 2007) thus it will be of interest to translate our findings into the hematopoietic system. In addition, the decreased sensitivity of Plzf À/À SPCs to GDNF mimics a reduced production of niche-signals; the decline in stem cell numbers in aging mouse testis is due partly to declining niche function and GDNF production (Ryu et al., 2006; Zhang et al., 2006) , thus loss of Plzf expression can represent a premature aging phenotype. Our studies therefore provide further insight into the association between stem cell maintenance, mTORC1, and aging (Harrison et al., 2009; Rossi et al., 2008) . A correlation between aging and cancer is also apparent, likely due to the accumulation of multiple genetic hits over time for tumor development (Rossi et al., 2008) . As stem cells are resident long-term in tissues and possess self-renewal capability (a feature of cancer stem cells), they are suggested to be the source of many cancers. However, loss of tumor suppressors (e.g., Pten, Pml) trigger stem cell depletion (Ito et al., 2009 ) and subsequent cancer development is associated with additional genetic hits (Guo et al., 2008) . It is proposed that oncogenic hits in stem cells elicit activation of fail-safe mechanisms that have to be evaded to allow cancer development ( Figure S6D ). These fail-safe mechanisms prevent propagation of clones of cells derived from stem cells with oncogenic mutations and the consequent risk of acquiring additional mutations that lead to cancer. The mTORC1 hyperactivation that occurs in response to loss of tumor suppressors such as Pten and Pml is likely a trigger of this fail-safe mechanism as rapamycin prevents stem cell exhaustion. Based on our new model, mTORC1 hyperactivation in response to oncogenic stimulation may also desensitize the cancer stem cell to niche-signals that are required for self-renewal; thus additional mutations supporting niche-independent self-renewal could allow cancer to develop ( Figure S6E ). PLZF was first identified from involvement in acute promyelocytic leukemia (APL) (Chen et al., 1993) . Thus, our model of Plzf-dependent SPC maintenance can have implications for leukemia pathogenesis. The ability of Plzf to inhibit mTORC1 through Redd1 induction may be relevant in this context given that perturbed PLZF function and elevated mTORC1 activity are associated with leukemia development (He et al., 2000; Martelli et al., 2007; McConnell and Licht, 2007) . In addition, REDD1 is involved in leukemic and myeloid cell differentiation (Gery et al., 2007; Nishioka et al., 2009) , suggesting that this gene can be a relevant PLZF target in hematopoietic cells. PML, also identified from its involvement in chromosomal translocations with the RARA gene in APL, is required for HSC maintenance and inhibits mTORC1 (Bernardi et al., 2006; Ito et al., 2008) ; thus illustrating a striking commonality of function between the RARA partners of APL.
We have identified a role for Plzf-mediated Redd1 expression in inhibiting mTORC1 activation in SPCs. As mTORC1 activity has a significant impact on the response of SPCs to GDNF, the tight regulation of this pathway is critical. Redd1 is also induced in response to cellular stress and in particular, by hypoxia (Brugarolas et al., 2004; Shoshani et al., 2002) . Interestingly, the HSC niche has been suggested to exist in a hypoxic state (Kubota et al., 2008; Parmar et al., 2007) that, if the SPC niche had similar characteristics, could be responsible for Redd1 induction. However, SPCs reside close to the vasculature in vivo (Yoshida et al., 2007) and Redd1 expression is maintained when SPCs are cultured at atmospheric oxygen levels. Thus Redd1 expression in this case depends on a Plzf tonic transcriptional activity and its induction is seemingly independent of hypoxia.
As mTORC1 inhibition enhances SPC function even in a WT setting, our data also have important therapeutic implications. It is tempting to speculate that rapamycin could be used to enhance SPC activity in humans; potentially allowing improved SPC culture from testicular biopsies and generation of therapeutically relevant MASCs ( Figure 6E ). Furthermore, our findings provide a novel and straightforward explanation for the requirement of Plzf in germline maintenance.
EXPERIMENTAL PROCEDURES Mouse Maintenance and Manipulation
Plzf À/À mice are previously described (Costoya et al., 2004) . Mice were treated with rapamycin (LC Laboratories) at a daily dose of 4 mg/kg as described (Yilmaz et al., 2006) . Transgenic mice expressing EGFP from the b-actin promoter were from Jackson Laboratories. Testis transplant assays were performed as described (Seandel et al., 2007) with 50 3 10 3 unfractionated or 5 3 10 3 av neg Thy-1 low c-Kit neg testis cells injected per recipient testis.
Teratoma formation assays in NOD/SCID mice (Jackson Laboratories) were performed as described (Seandel et al., 2007) .
Antibody Generation
Monoclonal anti-PLZF antibody (clone 9E12) was raised in Armenian hamster against a pool of keyhole limpet hemocyanin (KLH)-conjugated peptides at the Memorial Sloan-Kettering Cancer Center (MSKCC) antibody facility and reacts to a peptide within the hinge domain of mouse Plzf (RSKEGPGTPTRRSVIT SARE). Antibody was directly conjugated to Alexa 488 or Alexa 647 for use in flow cytometry (MSKCC antibody facility).
Flow Cytometry
Single cell suspensions were prepared from testis as described (Ogawa et al., 1997) and resuspended in phosphate-buffered saline (PBS) containing 2% fetal bovine serum (FBS) for subsequent staining and analysis (Filipponi et al., 2007) . For a detailed description of flow cytometry methods and antibodies used, refer to the Extended Experimental Procedures.
Cell Culture and Treatment SPC fractions from testis were plated directly onto mitotically inactivated MEF feeder cells. Medium for SPC culture was as previously described (Seandel et al., 2007) supplemented with 10 ng/ml IGF-I (Peprotech). MASCs and mouse ESCs (v6.5) were cultured in embryonic stem cell medium on MEF feeders (Seandel et al., 2007) . Knockdown of Redd1 expression in SPCs by shRNA was performed using pLKO.1 lentiviral vectors (Open Biosystems). A detailed description of methods is included in the Extended Experimental Procedures.
Immunofluorescence, Immunohistochemistry, and Western Blot Tissue and cultured cells were fixed in 4% paraformaldehyde before processing for immunofluorescence (IF) and immunohistochemistry (IHC) as described (Costoya et al., 2004; Filipponi et al., 2007) . For western blot analysis, cells were lysed in RIPA buffer and processed as described (Costoya et al., 2008) . Detailed methods are included in the Extended Experimental Procedures.
Chromatin Immunoprecipitation (ChIP) SPCs were trypsinized and resuspended in SPC medium then incubated in tissue culture dishes for 30 min to remove contaminating (adherent) MEFs. Preparation and immunoprecipitation of chromatin was performed using a SimpleChIP Enzymatic Chromatin IP kit (Cell Signaling Technology) according to manufacturers instructions and monoclonal anti-PLZF antibody (Calbiochem). DNA samples were analyzed by quantitative PCR using a QuantiTect SYBR Green PCR kit (QIAGEN) and Light Cycler (Roche). Primer sequences for the Redd1 promoter are included in the Extended Experimental Procedures.
Luciferase Assay REDD1 promoter constructs are described (Lin et al., 2005) and were cloned from U2OS genomic DNA into the pGL3-enhancer vector (Promega). Luciferase assays were performed with 293HEK cells as described (Barna et al., 2002) . Please refer to Extended Experimental Procedures for details.
Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) RNA was harvested using Trizol reagent (Invitrogen) then used for first strand cDNA synthesis and subsequent quantitative PCR analysis as described (Filipponi et al., 2007) . For primer sequences and detailed methodology please see Extended Experimental Procedures.
Statistical Analysis
Results from cell growth assays, testis transplants, and flow cytometry analysis were assessed for statistical significance by a standard two-tailed t test.
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